Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment

BACKGROUND: Ovarian cancer is the eighth most common cancer among women and due to late detection prognosis is poor with an overall 5-year survival of 30–50%. Novel biomarkers are needed to reduce diagnostic surgery and enable detection of early-stage cancer by population screening. We have previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Enroth, Stefan, Ivansson, Emma, Lindberg, Julia Hedlund, Lycke, Maria, Bergman, Jessica, Reneland, Anna, Stålberg, Karin, Sundfeldt, Karin, Gyllensten, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526736/
https://www.ncbi.nlm.nih.gov/pubmed/36196264
http://dx.doi.org/10.1038/s43856-022-00193-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526736/
https://www.ncbi.nlm.nih.gov/pubmed/36196264
http://dx.doi.org/10.1038/s43856-022-00193-6

Ejemplares similares